Genedata and Chugai Pharmaceuticals Sign Agreement

Basel, Switzerland (OBBeC) - Genedata, a provider of in silico solutions for pharmaceutical R&D and related life sciences, and Chugai Pharmaceutical, a Japanese research-based pharmaceutical company, have signed a multi-year contract for the use of the Genedata Expressionist system to streamline their internal R&D process.

“We are working with tens of thousands of GeneChip data sets. In the past, we were limited to normalizing small batches at a time. With Expressionist we can normalize the entire data set in one go,” said Mr. Junichi Muroya, member of the bioinformatics team at Chugai Pharmaceutical. “This has greatly increased processing speed, facilitated sophisticated statistical analysis and overall improved the quality of our results significantly.”

As part of their work in oncology and chronic diseases, researchers at Chugai have used Expressionist to perform a one-step, enterprise-wide normalization on their entire microarray data pool. Expressionist was also used to standardize the workflow-based microarray quality control process and obtain fully comparable data for subsequent data analysis.

“We are excited to work with Chugai, one of the most innovative pharmaceutical companies in Japan,” said Dr. Othmar Pfannes, CEO of Genedata. “Our partnership with Chugai is another example of Genedata’s successful expansion in the Japanese market. It also demonstrates the positive impact of our cutting-edge software and services on R&D productivity and how this ultimately saves time and money for our partners.”